Enhancer ID: | E_01_0996 |
Species: | human |
Position : | chr5:88714648-88716648 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Endometrial cancer |
Pubmed ID: | 32186750 |
Enhancer experiment: | RT-qPCR, DNA methylation analysis, cell viability assay, Western blot |
Enhancer experiment description: | EC cell lines transfected with vectors overexpressing miR?638, its target gene myocyte enhancer factor 2C (MEF2C) or both, were constructed. |
Target gene : | -- |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | EC cell lines transfected with vectors overexpressing miR?638, its target gene myocyte enhancer factor 2C (MEF2C) or both, were constructed. |
TF name : | MEF2C(5430401D19Rik,9930028G15Rik,AV011172,Mef2) |
TF experiment: | RT-QPCR?DNA?????????????Western blot |
TF experiment description: | EC cell lines transfected with vectors overexpressing miR?638, its target gene myocyte enhancer factor 2C (MEF2C) or both, were constructed. |
Enhancer function : | EC cell lines transfected with vectors overexpressing miR?638, its target gene myocyte enhancer factor 2C (MEF2C) or both, were constructed. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
EC cell lines transfected with vectors overexpressing miR?638, its target gene myocyte enhancer factor 2C (MEF2C) or both, were constructed. |
SNP ID: | -- |